NCT00335491 Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors Status COMPLETED Phase NA
NCT00332943 MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil Status COMPLETED Phase PHASE4
NCT00332163 Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy Status COMPLETED Phase PHASE2
NCT00331786 Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00327093 Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases Status TERMINATED Phase PHASE4
NCT00325871 Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer Status COMPLETED Phase N/A
NCT00324753 Quality Improvement of Patient-Provider Communication For Colorectal Cancer Screening Status COMPLETED Phase NA
NCT00323011 FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00321828 Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00316914 Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery Status COMPLETED Phase PHASE3
NCT00313859 Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC Status COMPLETED Phase PHASE2
NCT00311610 Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00310362 Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates Status COMPLETED Phase NA
NCT00310076 Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer Status COMPLETED Phase PHASE2
NCT00308516 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer Status COMPLETED Phase PHASE2
NCT00305643 Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer Status TERMINATED Phase PHASE3
NCT00303914 Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer Status COMPLETED Phase N/A
NCT00303875 Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight Status COMPLETED Phase PHASE2
NCT00303771 Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE3
NCT00303745 Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE2